AI-generated summary
This review examines emerging treatment options for vaginismus, drawing on PubMed, JSTOR and EBSCO searches from December 2024 to August 2025. The authors report that most studies evaluated multimodal approaches, with reported success rates ranging widely from 71 to 100 percent. They conclude that current evidence supports a multimodal approach, but heterogeneity in study design and outcome measures limits generalizability.
- Who or what was studied
- Individuals with vaginismus
- Limits stated in the abstract
- The authors note heterogeneity in study design, diagnostic criteria and outcome measures, limited long-term outcome data, and the need for larger, high-quality trials.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on degruyterbrill.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Laser, Heterogeneity, Biomarker. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.